Asthma & Allergies
» Updates in Advanced NSCLC: First-Line Treatment Selection of Immunotherapy Regimens
Updates in Advanced NSCLC: First-Line Treatment Selection of Immunotherapy Regimens
February 16, 2021
Rapid Reviews in Hematology™: Updates from San Diego on Therapeutic Advancements in Hemolytic Anemias – A Focus on Paroxysmal Nocturnal Hemoglobinuria
Community Practice Connections(TM): Optimizing Outcomes in Cold Agglutinin Disease: Exploring the Impact of Rapid Diagnosis and Emerging Therapeutic Agents
Community Practice Connections™: Understanding Cold Agglutinin Disease: How Do Emerging Treatment Options Have the Potential to Transform Patient Outcomes?
Post a comment to this article
(will not be displayed)
Report Abusive Comment
Thank you for helping us to improve our forums. Is this comment offensive? Please tell us why.